Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04162002 · ClinicalTrials.gov registry record · Phase 1
Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions
A Phase 1 study of Hand Rejuvination, sponsored by DeNova Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04162002 is a Phase 1 study of Hand Rejuvination that has completed, run by DeNova Research. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04162002, a Phase 1 study of Hand Rejuvination, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine the effects of Restylane® Lyft Filler injection into the back of the hand on first impressions.
Conditions Studied
Interventions
- DRUG Restylane® Lyft
Study Locations (1)
Illinois
- DeNova Research - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2019-11-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04162002
The ClinicalTrials.gov registry entry for NCT04162002 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hand Rejuvination appearing as the primary indexed condition, and to 1 intervention - of which Restylane® Lyft is the first listed.
NCT04162002 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04162002 about?
NCT04162002 is a clinical study titled "Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions". The purpose of this research is to determine the effects of Restylane® Lyft Filler injection into the back of the hand on first impressions.
What is the current status of trial NCT04162002?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-10-10. Estimated completion is 2019-11-18.
What conditions does trial NCT04162002 study?
This clinical trial studies the following conditions: Hand Rejuvination.
What interventions are being tested in trial NCT04162002?
The interventions under investigation include: Restylane® Lyft (DRUG).
Who is sponsoring clinical trial NCT04162002?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04162002 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.